Latest Conference Articles

It is important for pharmacists to stay on top of the latest drug safety communications from the FDA, which has provided numerous ways to accomplish that task, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

It is important for pharmacists to stay on top of the latest drug safety communications from the FDA, which has provided numerous ways to accomplish that task, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Marc Scheetz, PharmD, MS, BCPS-AQ ID, associate professor at Midwestern University and clinical pharmacist at Northwestern Medicine, discusses antimicrobial stewardship.

Pharmacists are always looking to identify emerging trends that will inevitably have an impact on their practice and patient care.

Mark Barricklow, RPh, discusses the challenges associated with centralized compounding parenteral nutrition.

William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.

Specialty market growth highlighted at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2016.

Tracy Glauser, MD—associate director of Neurology, Cincinnati Children's Hospital Medical Center—discusses the role of bioinformatics in health care.

Joseph Sullivan, MD—associate professor at the University of California San Francisco, director of USCF Pediatric Epilepsy Center—discusses some of the challenges in managing pediatric epilepsy.

Awards recognize best demonstrated practices and case studies designed to improve pharmacy processes, efficiency, and outcomes.

Trained clinical pharmacists can effectively manage patients with hepatitis C virus.

Trained clinical pharmacists can effectively manage patients with hepatitis C virus, according to research presented at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Several people were honored this week at Baxter Healthcare Corporation’s Leadership Excellence Awards in Pharmacy, or LEAP, ceremony.

Clinicians may face too many choices regarding the methods for screening patients with epilepsy for comorbidities.

Misuse of antimicrobial agents has contributed to a growing number of infections impervious to antibiotic treatments.

​Fred Massoomi, PharmD, discusses compounding options.

Petrea Cober, PharmD, BCNSP, BCPPS, discusses the challenges of parenteral nutrition education.

Arching Shrestha, MD, discusses the challenges of treating epilepsy in the elderly.

Sanjeev V. Thomas, MD, DM, FANA—professor of neurology, chairman of the Epilepsy Program, Sree Chitra Tirunal Institute—discusses why the risk of seizures is higher for women during the peripartum period.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy and classification of seizures differ from the previous versions.

Antibiotic resistance has become one of the most serious emerging threats to public health.

Antiepileptic drugs and seizures may harm a fetus, so it is important for physicians to plan an individualized treatment strategy for women with epilepsy.

Intradepartmental hospital pharmacy groups can play a key role in helping to identify and troubleshoot problem areas.

Collaboration between physicians, patients, and pharmacists is essential to address the public health crisis of opioid misuse and overdose in the United States.

Intradepartmental hospital pharmacy groups can play a key role in helping to identify and troubleshoot problem areas, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Collaboration between physicians, patients, and pharmacists is essential for addressing the public health crisis of opioid misuse and overdose in the United States, according to a presentation at the ASHP Midyear 2016 Clinical Meeting and Exhibition.

Christopher M. Jones, PharmD, CDR, US Public Health Service, discusses opportunities for pharmacists to reduce opioid prescription rates.

Jacqueline A. French, MD—professor of neurology, NYU Comprehensive Epilepsy Study Consortium, president, The Epilepsy Study Consortium—discusses how the new ILAE definition of epilepsy may change the disease.